Common Stock SEC Reporting - Current
Contact Info
  • 135 Beaver Street
  • Waltham, MA 02452

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001037649
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2835 - Diagnostic substances
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Mark B. Carbeau CEO
Stephen DiPalma Interim CFO
Company Directors
James M. Weaver Chairman
Mark B. Carbeau
Lionel Carrot
William C Mills III
Joseph M. Landstra
Dayton Misfeldt
Service Providers
Accounting/Auditing Firm
Grant Thornton LLP
226 Causeway Street
Boston, MA, 02114
United States
Securities Counsel
Mintz, Levin, Cohen, Ferris, Glovsky and Popeo, P.C.
One Financial Center
Boston, MA, 02111
United States
Investor Relations Firm

Not Available
Company History
  • Note=3-00 State of Incorporation Texas changed to Delaware
  • Formerly=Medical Science Systems, Inc. until 8-99
ILIU Security Details
Share Structure
Market Value1 $25,223,245 a/o Feb 17, 2017
Authorized Shares 650,000,000 a/o Oct 20, 2016
Outstanding Shares 252,232,448 a/o Nov 11, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 40,865,161 a/o Mar 27, 2016
Par Value 0.001
Shareholders of Record 122 a/o Apr 30, 2016
Short Selling Data
Short Interest 2,631 (-75.2%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security